Real Talk About Genetic Testing

May 10, 2018
Kristie L. Kahl
Kristie L. Kahl

Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.

We spoke with an expert about navigating at-home genetic testing kits, which are growing in popularity.

While at-home genetic testing becomes more popular, given its convenience and low cost, people should still access proper resources and talk to genetic counselors who can offer clear advice on the results and what you need to know about these tests.

In this week’s episode of CURE Talks Cancer, we spoke with Whitney Ducaine, who is the director of cancer genetics services at InformedDNA, to help explain exactly what you need to know about the FDA-approved 23AndMe test and why you should consult a genetic counselor about concerns and how to digest genetic testing results.

Read more.

Related Content:

Podcasts
Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
FDA Approvals from February 2024